Prospective Randomized Clinical Trial for no Inferiority With Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery (TEM) Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer

Trial Profile

Prospective Randomized Clinical Trial for no Inferiority With Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery (TEM) Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2015

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2015 Planned end date changed from 1 Dec 2013 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
    • 09 Sep 2015 Planned end date changed from 1 Dec 2015 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
    • 17 Jun 2011 Actual study start date reported in European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top